Equifax’s solid Q2 leads to price target hikes by Goldman Sachs, Baird, and Needham: Should you buy?
Equifax Inc. (NYSE: EFX) delivered a robust performance in its Q2 2024 earnings, surpassing expectations and igniting a flurry of optimistic reactions from financial analysts. Analysts at Goldman Sachs raised their target from $246 to $277, maintaining a ‘Neutral’ stance. Baird, seeing more potential, pushed their target from $260 to $290, sticking with an ‘Outperform’